China Solved 27,000 Drug Crime Cases in 2025, Seizures Up

China’s National Narcotics Control Commission (NNCC) announced on June 17 that anti-drug authorities solved 27,000 drug crime cases in 2025, arrested 41,000 suspects, and seized 33.5 tons of drugs, according to the “2025 China Drug Situation Report” released at a press conference in Beijing. While the number of cases and arrests declined year-on-year, drug seizures increased by 25.4%, signaling intensified enforcement against larger trafficking operations.

Context & Background

The report, released by the NNCC under the Ministry of Public Security, paints a nuanced picture of China’s ongoing “war on drugs.” The 27.6% decline in cases and 33% drop in arrests suggest shifting enforcement patterns, even as the volume of drugs intercepted rose sharply. At the same time, the number of identified drug users fell 30.3% to 134,000, while the total registered drug user population stood at 658,000 by the end of 2025, down 11.9% from the previous year.

Key Developments

According to CCTV News, Wei Xiaojun, Executive Deputy Director of the NNCC and Director of the Anti-Drug Bureau, stated that the “Qingyuan Duanshui” (Clear the Source, Cut the Flow) operation coordinated domestic and international fronts. Under this strategy, authorities deepened the “Jingbian” border operation to tighten drug interdiction across land, sea, air, and postal routes, seizing 18.7 tons of drugs originating from the Golden Triangle region — a 47.2% increase year-on-year.

Domestically, the “Chubing Sudu” (Eliminate Ice, Purge Drugs) operation led to the dismantling of 134 domestic drug manufacturing cases, with 5.3 tons of drugs seized, as reported by People’s Daily. The newspaper noted that large-scale drug manufacturing activities have been effectively curbed.

In a major international operation, Chinese authorities coordinated with Myanmar’s defense forces and police in January 2025 to destroy 13 drug manufacturing sites in northern Myanmar, seizing 2.47 tons of methamphetamine, 490 tons of controlled chemicals, and 83 large-scale reaction vessels. Wei Xiaojun described this as “the largest drug manufacturing facility seizure in Myanmar’s history.”

Emerging Drug Threats

The report highlighted a significant shift from traditional drugs to pharmaceutical and non-scheduled substances. Gao Wei, Deputy Director of the NNCC, told China News Service that public security departments solved 14,000 cases involving narcotic drugs and psychotropic substances in 2025, and identified 92,000 instances of abuse of non-scheduled addictive substances.

Nitrous oxide, or “laughing gas,” emerged as a particular concern, with authorities seizing 126.5 million liters — an 84% increase year-on-year. Other non-scheduled addictive substances saw a staggering 17.6-fold increase in seizures, reaching 9.3 tons.

Shan Yehua, another NNCC Deputy Director, announced that 16 new substances, including tiletamine and difluoroetomidate, have been added to China’s controlled substances list. Tiletamine, in particular, is being illegally manufactured and added to “head-getting electronic cigarettes” targeting youth. “It is highly addictive and poses great social harm,” Shan warned, as reported by Jiemian News. China now controls 412 substances plus three entire categories.

Youth Prevention

Encouragingly, the number of new drug users under 35 fell 41.6% year-on-year. The NNCC has launched a national campaign from June to December 2026 titled “You and I Participate, Protect the Future, Prevent Youth Drug Abuse,” focusing on education and early intervention.

Analysis & Implications

The 2025 data reveals a complex and evolving drug landscape in China. While traditional enforcement metrics show declines — possibly reflecting successful prevention and deterrence — the sharp rise in drug seizures and the explosion of non-scheduled substance abuse suggest that illicit drug markets are adapting. Criminal networks are shifting from traditional drugs like heroin to synthetic substances, pharmaceutical drugs, and novel psychoactive compounds that exploit regulatory gaps.

The surge in Golden Triangle-sourced methamphetamine (up 78.9%) underscores the persistent challenge of transnational drug trafficking. China’s deepening international cooperation — including joint operations with the US Drug Enforcement Administration, as seen in the “Jisheng” vessel case that netted nearly 5 tons of methamphetamine in the South China Sea — reflects a recognition that coordinated responses are essential.

What’s Next

As China adds 16 new substances to its controlled list and rolls out its youth-focused prevention campaign, authorities face the challenge of staying ahead of rapidly evolving drug trends. The rise of non-contact trafficking methods — using dark web platforms, encrypted messaging apps, and cryptocurrency payments — will require continued adaptation of enforcement strategies. The effectiveness of these measures will be closely watched as China seeks to maintain its position as one of the world’s most stringent anti-drug regimes.